References
- American Cancer Society. Cancer facts and figures. 1988.
- Pajak TF, Davis LW, Fazekas JT, Laramore GE. Prognostic factors in head and neck tumors for patients initially treated with radiation therapy. 1985; ASCO-C 772: 85.
- Wang CC, Blitzer PH, Suit HD. Twice-a-day radiation therapy for cancer of the head and neck. Cancer 1985; 55: 2100–2104.
- Saunders MI, Dische S, Hong A et al. Continuous hyperfractionated accelerated radiotherapy in locally advanced carcinoma of the head and neck region. Int J Radiat Oncol Biol Phys 1989; 17: 1287–1293.
- Taylor SG. Head and neck cancer. In: Cancer Chemotherapy 1979. The EORTC Cancer Chemotherapy Annual I.H.M. Pinedo (Ed) Excerpta Medica, Amsterdam. 1979: 237–256.
- Hong WK, Schaeffer S, Issel B et al. A prospective randomized trial of mehotrexate versus cisplatin in the treatment of recurrent squamous cell carcinoma of the head and neck. Cancer 1983; 52: 206–210.
- Al-Sarraf M, Pajak T, Marcial V. Concurrent radiotherapy and chemotherapy with cisplatinum in inoperable squamous cell carcinoma of the head and neck. An RTOG study. Cancer 1987; 59: 259–265.
- Rose WC, Schurig JE. Preclinical antitumor and toxicologic profile of carboplatin. Cancer Treat Rev 1985; 12 (Suppl. A): 1–19.
- Schweitzer VG, Rarey Ke, Dolan DF et al. Ototoxicity of cisplatin vs platinum analogs CBDCA(JM-8) and CHIP(JM-9). Otolaryngol Head Neck Surg 1986; 94: 458–470.
- Begg AC, van der Kolk PJ, Emondt J, Bartelink H. Radiosensitization in vitro by cis-diammine (1,1-cyclobutanedicarboxylato) platinum (II) (Carboplatinum, JM-8) and ethylendiammine-malanoplatinum (II) (JM 40). Radiother Oncol 1987; 9: 157–165.
- O’Hare JA, Douple EB, Richmond RC. Enhancement of radiation-induced cell kill by platinum complexes (carbopla-tin and iproplatin) in V 79 cells. Int J Radiat Oncol Biol Phys 1986; 12: 1419–1422.
- de Andres Basauri L, Lopez Pousa A. Carboplatin, an active drug in advanced head and neck cancer. Cancer Treat Rep 1986; 70: 1173–1176.
- Eisenberger M, Hornedo J, Silva H et al. Carboplatin (NSC-241–240): an active platinum analog for the treatment of squamous cell carcinoma of the head and neck. J Clin Oncol 1986; 4: 1506–1509.
- Forastiere AA, Natale RB, Takasugi BJ et al. A phase I-II trial of carboplatin and 5-fluorouracil combination chemotherapy in advanced carcinoma of the head and neck. J Clin Oncol 1987; 5: 190–196.
- Sinibalsi V, Eisenberger M, Jacobs M et al. Simultaneous carboplatin and conventional radiotherapy in advanced unresectable squamous cell carcinoma of the head and neck. Preliminary results of a phase I-II study. ASCO 1988; 7: A 593.
- Jacobs MC, Eisenberger M, Oh MC et al. Carboplatin (CBDCA) and radiotherapy for stage IV carcinoma of the head and neck: a phase I-II study. Int J Radiat Oncol Biol Phys 1989; 17: 361–363.